Safety and Efficacy of the Preserflo® Microshunt in Refractory Glaucoma: A One-Year Study
Open Access
- 29 November 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (23) , 7086
Abstract
Purpose: To evaluate the safety and efficacy of Preserflo® microshunt implantation in eyes with refractory glaucoma. Methods: In this retrospective study, a cohort of patients who underwent Preserflo® microshunt implantation between April 2019 and August 2020 for refractory glaucoma were evaluated. At the time of surgery, all eyes had uncontrolled intraocular pressure (IOP) despite maximally tolerated medical therapy and at least one previous failed glaucoma filtering surgery. The primary outcome was a complete success, defined as postoperative IOP ≤ 21 mm Hg with an IOP reduction ≥ 20% and no repeat filtering surgery. The secondary outcome was qualified success, defined as a complete success with the use of antiglaucoma medications. The rates of needling, bleb repair, and postoperative complications were also recorded. Results: Forty-seven eyes with a mean preoperative IOP of 30.1 ± 7.1 mm Hg and a mean of 3.4 ± 1 glaucoma medications were included. The mean number of previous surgeries prior to microshunt implantation was 2.3 ± 1.3. After 1 year, the mean IOP was significantly reduced to 18.8 ± 4.6 mm Hg, with the mean number of medications significantly reduced to 1.4 ± 1.2. Complete success was achieved in 35% of eyes, and a qualified success in 60% of eyes. A decrease in IOP of at least 30% was found in 55% of eyes. Needling or bleb repair was performed in 49% of eyes. Complications were minimal and transient, except for one eye which presented with tube extrusion, and another eye with a transected tube. A repeat glaucoma surgery had to be performed in 17% of eyes. Conclusions: The Preserflo® Microshunt provided moderate success but a significant reduction in IOP, with a good safety profile after one year of follow-up in eyes at high risk for failure of filtering surgery.Keywords
Funding Information
- Institut Hospitalo-Universitaire (IHU) FOReSIGHT, Paris
This publication has 27 references indexed in Scilit:
- Postoperative Complications in the Ahmed Baerveldt Comparison Study During Five Years of Follow-upAmerican Journal of Ophthalmology, 2016
- Intraocular Pressure Outcomes and Risk Factors for Failure in the Collaborative Bleb-Related Infection Incidence and Treatment StudyOphthalmology, 2015
- Factors Correlating With Failure to Control Intraocular Pressure in Primary Angle-Closure Glaucoma Eyes With Coexisting Cataract Treated by Phacoemulsification or Combined PhacotrabeculectomyAsia-Pacific Journal of Ophthalmology, 2015
- Treatment Outcomes in the Tube Versus Trabeculectomy (TVT) Study After Five Years of Follow-upAmerican Journal of Ophthalmology, 2012
- Micro-invasive glaucoma surgeryCurrent Opinion in Ophthalmology, 2012
- The Ahmed Versus Baerveldt StudyOphthalmology, 2011
- Long-term Outcomes of Repeat vs Initial Trabeculectomy in Open-Angle GlaucomaAmerican Journal of Ophthalmology, 2009
- Treatment Outcomes in the Tube Versus Trabeculectomy Study After One Year of Follow-upAmerican Journal of Ophthalmology, 2007
- Categorizing the Stage of Glaucoma From Pre-Diagnosis to End-Stage DiseaseAmerican Journal of Ophthalmology, 2006
- Trabeculectomy with Simultaneous Topical Application of Mitomycin-C in Refractory GlaucomaJournal of Ocular Pharmacology and Therapeutics, 1990